Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pristine Cream (also known as PRISTINE) is a patented, proprietary Ayurvedic skin-healing cream developed and manufactured by Bombay Hemp Company (BOHECO). Formulated with full-spectrum Vijaya (Cannabis sativa) leaf extract, the cream is rich in cannabinoids that interact locally with the skin's endocannabinoid system (ECS) to modulate CB1 and CB2 receptor activity. This interaction helps reduce inflammatory skin responses, calm itching, and support skin barrier repair. Pristine Cream is indicated for the management of chronic inflammatory skin conditions, including eczema, psoriasis, dermatitis, and persistent dry skin. It has been clinically tested in collaboration with the National Institute of Ayurveda, Jaipur, demonstrating significant improvements in Eczema Area and Severity Index (EASI) scores, itching, and dryness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pristine Cream.